Kim et al. found that ZHX1 could be used as a bridge to recruit DNMT3B to bind with other inhibitory proteins, thus promoting DNMT3B-mediated transcriptional inhibition, which to some extent explained the important inhibitory effect of ZHX1 in malignant diseases such as cancer [48]. The gene discussed is DNMT3B; the disease is cancer.